Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892938 · ClinicalTrials.gov registry record
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
A clinical trial of Bradycardia and Arrhythmias, Cardiac, sponsored by Everbeat.
- Active
- Registry status
- 232
- Enrollment target
- 3
- Study locations
NCT06892938: Active study of Bradycardia and Arrhythmias, Cardiac, sponsored by Everbeat.
NCT06892938 is a study of Bradycardia and Arrhythmias, Cardiac that is active but no longer recruiting, run by Everbeat. The registered enrollment target is 232 participants, below the 4,405-participant average among 29 other Bradycardia trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892938, a study of Bradycardia and Arrhythmias, Cardiac, is active but no longer recruiting, sponsored by Everbeat.
- ACTIVE NOT RECRUITING
- Registry status
- 232 participants
- Enrollment target
- 3
- Study locations
Study Summary
Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.
Primary Outcome
Automated rhythm characterization by the ring device as normal sinus rhythm, atrial fibrillation or other.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Atrial Fibrillation Identification
Study Locations (3)
California
- XIMED - La Jolla
Louisiana
- Our Lady of Lake Hospital - Baton Rouge
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2024-09-17 |
| Est. Completion | 2025-04-01 |
What the registry record for NCT06892938 still lists
NCT06892938 is an observational study that tracks outcomes without assigning an intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 4,405-participant average among 29 other Bradycardia trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Atrial Fibrillation Identification is the first listed.
NCT06892938 reports a single indexed study location in California, Louisiana, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06892938 about?
NCT06892938 is a clinical study titled "Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring". Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grad...
What is the current status of trial NCT06892938?
This trial is currently active not recruiting. The enrollment target is 232 participants. The study started on 2024-09-17. Estimated completion is 2025-04-01.
What conditions does trial NCT06892938 study?
This clinical trial studies the following conditions: Bradycardia, Arrhythmias, Cardiac, Atrial Fibrillation (AF), Tachycardia, Palpitations.
What interventions are being tested in trial NCT06892938?
The interventions under investigation include: Atrial Fibrillation Identification (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06892938?
This trial is sponsored by Everbeat, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892938 being conducted?
This trial has 3 study locations across California, Louisiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06892938's enrollment target sits among peer trials
232 21st of 29 higher than 9 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI